Abiomed Inc
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
Abiomed Inc logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 908 (as per FY 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker ABMDno data available
Financial year endsFY ends End of Marchno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17100120140160180
datesClosing price (adj.)
13.10.2017173.85
11.10.2017172.66
04.10.2017171.80
27.09.2017163.72
20.09.2017157.42
13.09.2017158.46
06.09.2017151.61
30.08.2017147.48
23.08.2017152.90
16.08.2017155.16
09.08.2017155.85
02.08.2017146.44
26.07.2017145.08
19.07.2017144.55
12.07.2017144.08
05.07.2017142.38
27.06.2017140.47
20.06.2017144.46
13.06.2017140.65
06.06.2017142.15
30.05.2017139.72
23.05.2017134.74
16.05.2017133.84
09.05.2017130.88
02.05.2017134.28
25.04.2017129.16
18.04.2017121.17
11.04.2017125.87
04.04.2017124.08
28.03.2017125.05
21.03.2017122.27
14.03.2017120.53
07.03.2017120.03
28.02.2017117.97
21.02.2017117.81
14.02.2017108.96
07.02.2017109.94
31.01.2017106.37
24.01.2017112.30
17.01.2017114.02
10.01.2017112.24
03.01.2017112.36
27.12.2016113.74
19.12.2016116.77
12.12.2016119.06
05.12.2016109.95
28.11.2016112.22
21.11.2016115.81
14.11.2016110.01
07.11.2016107.34
31.10.2016104.99
24.10.2016125.61
17.10.2016127.95
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 173.85n/a
Market Capitalisation
in million USD
 7,593n/a
Enterprise Value
in million USD
 7,379n/a
Common Shares Outstanding
as per Mar 31, 2017
 43,673,286n/a
Preferred Shares Outstanding
as per Mar 31, 2017
 n/a
Average Basic Shares Outstanding
TTM
 43,238,000n/a
Average Diluted Shares Outstanding
TTM
 44,658,000n/a
Index Membership
n/a
Business Summary
Abiomed Inc is a medical device company. It provides mechanical circulatory support devices to aid heart recovery to heart failure patients.
no data available
Key Financials & Ratios (all figures TTM as per Mar 31, 2017, million USD, full statements further below)
Profit & Loss
Revenues 445n/a
Gross Profit 375n/a
Operating Income 90n/a
EBITDA 96n/a
Net Profit 52n/a
Balance Sheet
Cash and Cash Equivalents 230n/a
Receivables 54n/a
Total Current Assets 327n/a
PP&E 88n/a
Total Assets 550n/a
Accounts Payable 21n/a
Current Debt 1n/a
Total Current Liabilities 70n/a
Long-Term Debt 16n/a
Total Liabilities 98n/a
Total Equity 452n/a
Cash Flow
Depreciation & Amortisation 6n/a
Change in Working Capital 7n/a
Operating Cash Flow 115n/a
Net Change in PP&E and Intangibles -50n/a
Investing Cash Flow -126n/a
Dividends Paid 0n/a
Financing Cash Flow 4n/a
Total Change in Cash -9n/a
Free Cash Flow 14n/a
Profitability Ratios
Gross Margin 84.1%n/a
Operating Margin 20.2%n/a
Net Profit Margin 11.7%n/a
Return on Equity 11.5%n/a
Return on Assets 9.5%n/a
Per Share Figures
Basic EPS 1.21n/a
Diluted EPS 1.17n/a
Sales per Share 10.30n/a
Book Value per Share 10.46n/a
FCF per Share 0.32n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 144.23n/a
Price to Sales Ratio 16.88n/a
Price to Book Value 16.63n/a
Price to Free Cash Flow 551.86n/a
Valuation Metrics
EV/EBITDA 76.59n/a
EV/Sales 16.57n/a
Book to Market Value 0.06n/a
Other Ratios
Current Ratio 469.7%n/a
Liabilities to Equity Ratio 21.8%n/a
Debt to Assets Ratio 3.0%n/a
Profit & Loss StatementP&L data quality: 79% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16FY '17
Revenue
86
101
126
158
184
230
330
445
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-23
-22
-25
-32
-37
-40
-50
-71
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
63
79
102
127
146
190
279
375
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-88
-90
-100
-110
-138
-162
-214
-285
Selling, General & Administrative
-61
-62
-72
-84
-107
-126
-164
-218
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-26
-27
-27
-26
-31
-36
-50
-66
Depreciation & Amortization
-1
-1
-1
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
-25
-11
2
17
8
29
65
90
Non-Operating Income (Loss)
0
0
0
0
0
0
1
1
Interest Expense, net
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
2
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-25
-11
2
17
9
29
66
91
Abnormal Gains (Losses)
-6
0
-1
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
-31
-12
1
17
9
29
66
91
Income Tax (Expense) Benefit, net
-1
-1
-1
-2
-1
85
-28
-39
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-32
-13
-1
15
7
114
38
52
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-32
-13
-1
15
7
114
38
52
Minority Interest
0
0
0
0
0
0
0
0
Net Income
-32
-13
-1
15
7
114
38
52
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-32
-13
-1
15
7
114
38
52
Remarks
restated on Jun 4, 2012 n/a
calculated values,
restated on May 28, 2013 n/a
calculated values,
restated on May 28, 2014 n/a
calculated values,
restated on May 28, 2015 n/a
calculated values,
restated on May 26, 2016 n/a
calculated values,
restated on May 25, 2017 n/a
calculated values,
restated on May 25, 2017 n/a
calculated values,
restated on May 25, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16FY '17
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
60
77
77
77
132
212
230
Cash & Cash Equivalents
n/a
6
6
9
21
22
48
39
Short Term Investments
n/a
54
71
67
56
110
164
191
Accounts & Notes Receivable
n/a
15
20
23
24
32
43
54
Accounts Receivable, Net
n/a
15
20
23
24
32
43
54
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
8
11
15
14
17
27
35
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
2
2
2
3
4
7
8
Prepaid Expenses
n/a
2
2
2
3
4
7
8
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
Total Current Assets
n/a
85
111
117
118
185
288
327
Property, Plant & Equipment, Net
n/a
6
6
7
7
9
23
88
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
11
42
14
1
47
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
41
37
35
39
130
111
89
Intangible Assets
n/a
2
0
0
0
15
15
14
Goodwill
n/a
39
37
35
38
32
33
31
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
80
59
35
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
1
4
4
8
Total Noncurrent Assets
n/a
47
43
53
87
153
136
223
Total Assets
n/a
132
154
170
205
338
424
550
Liabilities and owners' equity
Payables & Accruals
n/a
20 20361000
19 19390000
23 22858000
26 25645000
32 32283000
38 37763000
58 58323000
Accounts Payable
n/a
6 6283000
7 6910000
8 7696000
8 7746000
10 10389000
9 9381000
21 20620000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
14 14078000
12 12480000
15 15162000
18 17899000
22 21894000
28 28382000
38 37703000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
1 799000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
2 1982000
3 3025000
4 4198000
5 4766000
7 7036000
9 8778000
10 10495000
Deferred Revenue
n/a
2 1982000
3 3025000
4 4198000
5 4766000
7 7036000
9 8778000
10 10495000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
22 22343000
22 22415000
27 27056000
30 30411000
39 39319000
47 46541000
70 69617000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
16 15539000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
5 4502000
5 5199000
6 5863000
7 6643000
7 7488000
9 8615000
13 13187000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
4 4010000
5 4799000
6 5554000
6 6415000
1 795000
1 832000
1 783000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 492000
0 400000
0 309000
0 228000
7 6693000
8 7783000
12 12404000
Total Noncurrent Liabilities
n/a
5 4502000
5 5199000
6 5863000
7 6643000
7 7488000
9 8615000
29 28726000
Total Liabilities
n/a
27 26845000
28 27614000
33 32919000
37 37054000
47 46807000
55 55156000
98 98343000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
380 379595000
402 402164000
415 415207000
437 436547000
465 465459000
509 509050000
566 566399000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-1 -827000
-1 -827000
-16 -16129000
-17 -16554000
-19 -19347000
-27 -26660000
-47 -46763000
Retained Earnings
n/a
-275 -274770000
-273 -273275000
-258 -258261000
-251 -250910000
-137 -137222000
-99 -99075000
-47 -46959000
Other Equity
n/a
1 745000
-2 -1765000
-4 -3737000
-1 -730000
-17 -17330000
-15 -14540000
-21 -20606000
Equity Before Minority Interest
n/a
105 104743000
126 126297000
137 137080000
168 168353000
292 291560000
369 368775000
452 452071000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
105 104743000
126 126297000
137 137080000
168 168353000
292 291560000
369 368775000
452 452071000
Total Liabilities & Equity
n/a
132 131588000
154 153911000
170 169999000
205 205407000
338 338367000
424 423931000
550 550414000
Remarks restated on n/a restated on Jun 4, 2012 n/a restated on May 28, 2013 n/a restated on May 28, 2014 n/a restated on May 28, 2015 n/a restated on May 26, 2016 n/a restated on May 25, 2017 n/a restated on May 25, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16FY '17
Net Income/Starting Line
-19
-12
1
15
7
114
38
52
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
5
4
4
3
3
3
3
6
Non-Cash Items
10
9
11
11
14
-69
50
50
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
-3
0
-13
-3
-1
-4
-15
7
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
-7
2
4
26
23
43
77
115
Change in Fixed Assets & Intangibles
-2
-2
-2
-3
-3
-5
-16
-50
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
6
-1
-16
-7
-19
-26
-41
-73
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-2
0
0
0
0
-16
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
-1
-3
-1
-3
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
2
-3
-17
-10
-22
-50
-58
-126
Dividends Paid
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
0
0
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
1
1
14
-12
9
11
10
11
Increase in Capital Stock
1
1
14
3
9
11
10
11
Decrease in Capital Stock
0
0
0
-15
0
0
0
0
Other Financing Activities
7
1
0
0
0
-1
-3
-6
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
7
2
15
-12
10
10
7
4
Net Cash Before Disc. Operations and FX
2
1
1
4
11
3
26
-7
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
2
1
1
4
11
3
26
-7
Effect of Foreign Exchange Rates
1
0
-1
-1
1
-1
0
-2
Net Changes in Cash
3
1
0
3
11
1
26
-9
Remarks
restated on Jun 4, 2012 n/a
calculated values,
restated on May 28, 2013 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on May 28, 2015 n/a
calculated values,
restated on May 26, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on May 25, 2017 n/a
calculated values,
restated on May 25, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo